← Open Payments lookup

STEVEN LESTER: Open Payments

NPI 1902688377 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 44 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $233 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$177
Vanda Pharmaceuticals Inc.2$150
ABBVIE INC.13$135
Otsuka America Pharmaceutical, Inc.6$132
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$105
Janssen Pharmaceuticals, Inc2$42
Takeda Pharmaceuticals U.S.A., Inc.2$38
Daiichi Sankyo Inc.1$27
Exact Sciences Corporation1$23
Novo Nordisk Inc1$20

Products named: INGREZZA, REXULTI, FANAPT, VRAYLAR, CAPLYTA, SPRAVATO, TRINTELLIX, INJECTAFER.

Industry payments across VA — which companies pay providers there.